Merck’s Covid-19 drug may soon get to the poor countries


The Bill and Melinda Gates Foundation says that millions of courses of Merck’s promising pill for Covid-19 could begin to reach lower-income countries early in 2022 as the charity kicks in as much as $120-m to widen global access to the therapy. The funds will help spur generic-drugs manufacturers, some of which have indicated they could produce as many as 10-m treatments a month, according to Trevor Mundel, president of the global health division at the Gates foundation. – Business Day (21 Otober 2021).

The foundation urged other donors to devote resources to accelerating the rollout of Merck’s experimental molnupiravir to poorer nations if it’s approved.

Other news